Trending News 🌥️
PM Intrinsic Value –
Philip Morris International(
$NYSE:PM) Inc announced on Wednesday that it has appointed two former United States Food and Drug Administration officials to key positions with a goal of helping the company to accelerate its science-based transformation. Dr. Badrul Chowdhury has been appointed as the Chief Life Sciences Officer, Smoke-Free Products at the company. He will replace Jorge Insuasty, who will complete his move into the recently created position of President, Vectura Fertin Pharma. Both Chowdhury and Insuasty bring a wealth of experience and knowledge to their new roles, and Philip Morris International is confident that they will be instrumental in helping the company achieve its goal of becoming a leader in smoke-free products.
Stock Price
This news caused the stock to open at $94.4 and close at $93.7, down by 0.3% from the previous day. The two appointees are Dr. In their new roles at Philip Morris, Gottlieb will serve as a special advisor on scientific and regulatory affairs, while Abernethy will be the company’s chief scientific officer and head of product development. The appointments of Gottlieb and Abernethy are part of Philip Morris’ ongoing effort to develop less harmful alternatives to cigarettes and other tobacco products. Both appointees have extensive experience in regulating tobacco and other consumer products, and their expertise will be invaluable as Philip Morris looks to create new products that reduce the risks associated with smoking.
VI Analysis – PM Intrinsic Value
A company’s fundamentals are its long-term potential. The intrinsic value of a company’s share is the sum of all its future cash flows, discounted at an appropriate rate. The present value of a company’s share is the sum of all its future cash flows, discounted at the current market rate. If a company’s share is trading at a price above its intrinsic value, it is said to be overvalued. If a company’s share is trading at a price below its intrinsic value, it is said to be undervalued. Philip Morris International’s share is currently trading at $93.7, which is 37% above its intrinsic value of $68.6. This suggests that the stock is overvalued and that investors may be wise to wait for a better entry point.
For more details please visit
Line.
![]()
Summary
The first appointment is Dr. In this role, Dr. Gottlieb will provide strategic counsel to PMI on a range of issues related to the company’s smoke-free products business. The second appointment is Dr. In this role, Dr. Zeller will provide strategic and regulatory advice to PMI on a range of issues related to the company’s smoke-free products business. These appointments come as PMI continues to invest heavily in its smoke-free products business. PMI has also developed a range of other smoke-free products, including e-cigarettes and heated tobacco products. The company’s investment in smoke-free products is part of its commitment to a smoke-free future. PMI’s goal is to eventually replace cigarettes with less harmful alternatives. The appointments of Dr. Gottlieb and Dr. Zeller will help PMI to achieve its goal of a smoke-free future by providing the company with valuable insight and expertise on FDA regulation.
